Provided by Tiger Trade Technology Pte. Ltd.

Palisade Bio Inc.

1.64
+0.14009.33%
Post-market: 1.670.0300+1.83%19:57 EST
Volume:2.92M
Turnover:4.76M
Market Cap:244.36M
PE:-0.70
High:1.68
Open:1.51
Low:1.51
Close:1.50
52wk High:2.64
52wk Low:0.5300
Shares:149.00M
Float Shares:105.00M
Volume Ratio:0.76
T/O Rate:2.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3306
EPS(LYR):-10.1929
ROE:-228.64%
ROA:-87.81%
PB:76.12
PE(LYR):-0.16

Loading ...

Company Profile

Company Name:
Palisade Bio Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
8
Office Location:
7750 El Camino Real,Suite 2A,Carlsbad,California,United States
Zip Code:
92009
Fax:
- -
Introduction:
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor tranexamic acid to reduce the formation of postoperative adhesions, postoperative ileus, and return of bowel function in adults. It has a license agreement with the Regents of the University of California; and co-development and distribution agreement with Newsoara Biopharma Co., Ltd. Palisade Bio, Inc. is based in Carlsbad, California.

Directors

Name
Position
Donald Williams
Chairman and Director
J. D. Finley
Chief Executive Officer, Chief Financial Officer and Director
Binxian Wei
Director
Emil Chuang
Director

Shareholders

Name
Position
J. D. Finley
Chief Executive Officer, Chief Financial Officer and Director
Mitchell Jones
Chief Medical Officer